OncBioMune Pharmaceuticals, Inc | Purchase Agreements | Business Contracts

Form of Securities Purchase Agreement (Filed With SEC on December 1, 2022)

Form of Securities Purchase Agreement for April 2022 (Filed With SEC on May 23, 2022)

Form of Securities Purchase Agreement (Filed With SEC on February 3, 2022)

Securities Purchase Agreement, dated November 1, 2021 (Filed With SEC on November 5, 2021)

Securities Purchase Agreement, dated July 30, 2021 (Filed With SEC on August 6, 2021)

Securities Purchase Agreement, dated May 12, 2021 (Filed With SEC on May 19, 2021)

Securities Purchase Agreement, dated September 16, 2020, by and among OncBioMune Pharmaceuticals, Inc. and the Investor (Filed With SEC on September 22, 2020)

Securities Purchase Agreement, dated June 5, 2020, by and among OncBioMune Pharmaceuticals, Inc. Cavalry Fund I LP and Lincoln Park Capital Fund, LLC (Filed With SEC on June 11, 2020)

Asset Purchase Agreement, dated May 12, 2020, between OncBioMune Pharmaceuticals, Inc. and Avant Diagnostics, Inc (Filed With SEC on May 13, 2020)

Securities Purchase Agreement dated September 25, 2019 (Filed With SEC on November 19, 2019)

Securities Purchase Agreement (Filed With SEC on August 6, 2019)

Form of Securities Purchase Agreement (Filed With SEC on July 18, 2019)

Form of Securities Purchase Agreement (Filed With SEC on May 2, 2019)

Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Cavalry Fund I LP, dated March 25, 2019 (Filed With SEC on April 1, 2019)

Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and Cerberus Finance Group Ltd (Filed With SEC on February 4, 2019)

Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and LG Capital Funding LLC (Filed With SEC on January 29, 2019)

OncBioMune Pharmaceuticals, Inc (62) | Purchase Agreements (16)